CSIMarket Company Name, Ticker, Customers, else..


Gohealth Inc   (NASDAQ: GOCO)
Other Ticker:  
 
    Sector • Financial    Industry • Insurance Brokerage
   Industry • Insurance Brokerage
   Sector • Financial


 

Gohealth Inc

GOCO's Financial Statements and Analysis



Gohealth Inc reported in the third quarter of 2024 net earnings per share of $0.46 an improvement compare to net loss per share of $-2.61 recorded a year ago and an improvement compare to net loss per share of $-2.70 realized in previous quarter.


third quarter of 2024
Earnings Per Share Revenues
$ 0.46 $  118 Mill
$+3.07     $-14M     -10.41 %



Gohealth Inc 's Revenue fell by -10.41 % in third quarter of 2024 (Sep 30 2024) year on year, to $118 million and advanced by 11.73 % sequentially.


Gohealth Inc is

More on GOCO's Income Statement



Gohealth Inc 's net income of $15.366 million in the third quarter of 2024 increased from net loss of $-56.204 million III. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $-59.314 million recorded in previous quarter.

More on GOCO's Growth

Gohealth Inc Inventories
GOCO's Cash flow In the third quarter of 2024 company's net cash flow was $21 million, capital expenditures fell by -3.42724.10%, to $-4 millions compare to same quarter a year ago

More on GOCO's Cash flow Statement


Gohealth Inc does not pay out common stock dividend.

In trailing twelve-month period Gohealth Inc earned $ 2.41 cash per share, on a free-cash flow basis .

Book value fell by -27.95 % sequentially to $23.68 per share, -269.63% of net loss per share in trailing twelve-month period were subtructed from shareholder value.


Company issued 4.61 million shares or 46.19 % in Sep 30 2024.


• More on GOCO's Dividends

 Market Capitalization (Millions) 157
 Shares Outstanding (Millions) 15
 Total Debt (Millions $) 481
 Revenue (TTM) (Millions $) 686
 Net Income (TTM) (Millions $) -68
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) -17
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1,247




Gohealth Inc does not pay out common stock dividend.

In trailing twelve-month period Gohealth Inc had $ 2.41 cash flow per share, on a free-cash flow basis .

Book value fell by -27.95 % sequentially to $23.68 per share, -269.63% of net loss per share in trailing twelve-month period were subtructed from shareholder value.


Company issued 4.61 million shares or 46.19 % in Sep 30 2024.


• More on GOCO's Balance Sheets

 Market Capitalization (Millions) 157
 Shares Outstanding (Millions) 15
 Total Debt (Millions $) 481
 Revenue (TTM) (Millions $) 686
 Net Income (TTM) (Millions $) -68
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) -17
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1,247
   


  News about Gohealth Inc Earnings

Gohealth Inc Reports Loss Despite Revenue Improvement in Financial Time-Frame Ending March 31, 2024

Gohealth Inc, a leading health insurance marketplace and Medicare-focused digital health company, has seen an increase in its shares over the past year. The company's shares have increased by 5.64% from a year ago and by 5.64% from a year before. However, it is important to note that Gohealth Inc shares are currently trading only 16.2% above its 52 week low.
Despite the increase in shares, Gohealth Inc reported a loss of $-1.04 per share for the financial time-frame ending March 31, 2024. This is lower than the loss of $-1.12 per share reported in the previous year, but still represents a significant deficit for the company. The company's revenue grew by only 1.333% to $185.60 million from $183.16 millio...

GOCO Reports Very Strong Data in Fourth Quarter of 2023 Earnings Season

During the trailing 30 days, Gohealth Inc stock experienced a 1.31% improvement, while GOCO stock saw a 3.62% improvement over the past five trading days. ...

Gohealth Inc Faces Challenging Market Environment with Significant Stock Decline, but Shows Promising Upside Potential in 2023

Gohealth Inc, a leading Insurance Brokerage company, has experienced a significant decline in its stock performance over the past three months. The stock has decreased by 28.62% during this time period, reflecting a challenging market environment for the company. However, there is some positive news as well, as the stock has seen a 31.49% increase in value in the year 2023.
Currently trading on the NASDAQ, Gohealth Inc's stock is trading 10.1% below its 52-week average. This indicates that the stock is currently undervalued in the market, presenting a potential buying opportunity for investors. It is worth noting that the stock's performance is influenced by various factors, including market conditions, ...

GoHealth Inc: Successfully Navigating Challenging Waters, Expertly Overcoming -10.006% Revenue Decrease in Q2 2023!



Gohealth Inc, a leading healthcare technology platform, recently released its financial report for the fiscal interval of April to June 30, 2023. The company witnessed a significant increase in its deficit per share and a decrease in revenue compared to the previous year. However, the shares of Gohealth Inc have experienced solid gains in recent trading and have shown substantial growth throughout 2023.
Deficit and Revenue Analysis:
During the April to June 30, 2023 fiscal interval, Gohealth Inc recorded a deficit per share of $-3.27, a substantial increase from the $-0.35 deficit reported in the same period last year. Additionally, the deficit increased from the previous reporting period's...

GOCO's Revenue Takes a Tumble in Q1 2023, Gohealth Inc. Reports

Gohealth Inc. has recently reported its financial performance for the first quarter of 2023. The company's earnings results show a significant decline in revenue and an increase in loss per share compared to the same period a year earlier. In this article, we will dig deeper into the financial numbers and provide an analysis of Gohealth Inc.'s Q1 performance.
Revenue
According to the financial report, Gohealth Inc.'s revenue for the first quarter of 2023 was $183.16 million, which represents a decline of 32.312% compared to the same quarter in 2022, where revenue stood at $270.59 million. Although this represents a large decline, it must be noted that the company's sequential revenue increased by 164...


Date modified: 2024-11-10T08:38:55+00:00





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com